The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial

Zoe McQuilten; Nicholas C Wong; Anna Leichter; Le TP Thao; James Phung; Andrew J Murphy; Moeen Riaz; Robert Sebra; Alexander G Bick; John J McNeil; Rory Wolfe; Robyn L. Woods; Paul Lacaze; Erica M. Wood; David J. Curtis

doi:10.1182/blood-2022-170761

The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial

Zoe McQuilten, Nicholas C Wong, Anna Leichter, Le TP Thao, James Phung, Andrew J Murphy, Moeen Riaz, Robert Sebra, Alexander G Bick, John J McNeil, Rory Wolfe, Robyn L. Woods, Paul Lacaze, Erica M. Wood, David J. Curtis

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	2238-2239
Number of pages	2
Journal	Blood
Volume	140
Issue number	Supplement 1
DOIs	https://doi.org/10.1182/blood-2022-170761
Publication status	Published - 15 Nov 2022
Event	Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022 - New Orleans, United States of America Duration: 10 Dec 2022 → 13 Dec 2022 Conference number: 64th https://www.sciencedirect.com/journal/blood/vol/140/suppl/S1 (Meeting abstract published in Supplementary Issue of Blood) https://www.hematology.org/meetings/annual-meeting

Access to Document

10.1182/blood-2022-170761

Cite this

McQuilten, Z., Wong, N. C., Leichter, A., Thao, L. TP., Phung, J., Murphy, A. J., Riaz, M., Sebra, R., Bick, A. G., McNeil, J. J., Wolfe, R., Woods, R. L., Lacaze, P., Wood, E. M., & Curtis, D. J. (2022). The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial. Blood, 140(Supplement 1), 2238-2239. https://doi.org/10.1182/blood-2022-170761

@article{03afea9cfa504289b3ecd964afd9b148,

title = "The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial",

author = "Zoe McQuilten and Wong, {Nicholas C} and Anna Leichter and Thao, {Le TP} and James Phung and Murphy, {Andrew J} and Moeen Riaz and Robert Sebra and Bick, {Alexander G} and McNeil, {John J} and Rory Wolfe and Woods, {Robyn L.} and Paul Lacaze and Wood, {Erica M.} and Curtis, {David J.}",

year = "2022",

month = nov,

day = "15",

doi = "10.1182/blood-2022-170761",

language = "English",

volume = "140",

pages = "2238--2239",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "Supplement 1",

note = "Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022, ASH 2022 ; Conference date: 10-12-2022 Through 13-12-2022",

url = "https://www.sciencedirect.com/journal/blood/vol/140/suppl/S1, https://www.hematology.org/meetings/annual-meeting",

}

McQuilten, Z, Wong, NC, Leichter, A, Thao, LTP, Phung, J, Murphy, AJ, Riaz, M, Sebra, R, Bick, AG, McNeil, JJ , Wolfe, R , Woods, RL , Lacaze, P , Wood, EM & Curtis, DJ 2022, 'The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial', Blood, vol. 140, no. Supplement 1, pp. 2238-2239. https://doi.org/10.1182/blood-2022-170761

The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial. / McQuilten, Zoe; Wong, Nicholas C; Leichter, Anna et al.
In: Blood, Vol. 140, No. Supplement 1, 15.11.2022, p. 2238-2239.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly

T2 - Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) 2022

AU - McQuilten, Zoe

AU - Wong, Nicholas C

AU - Leichter, Anna

AU - Thao, Le TP

AU - Phung, James

AU - Murphy, Andrew J

AU - Riaz, Moeen

AU - Sebra, Robert

AU - Bick, Alexander G

AU - McNeil, John J

AU - Wolfe, Rory

AU - Woods, Robyn L.

AU - Lacaze, Paul

AU - Wood, Erica M.

AU - Curtis, David J.

N1 - Conference code: 64th

PY - 2022/11/15

Y1 - 2022/11/15

U2 - 10.1182/blood-2022-170761

DO - 10.1182/blood-2022-170761

M3 - Meeting Abstract

SN - 0006-4971

VL - 140

SP - 2238

EP - 2239

JO - Blood

JF - Blood

IS - Supplement 1

Y2 - 10 December 2022 through 13 December 2022

ER -

McQuilten Z, Wong NC, Leichter A, Thao LTP, Phung J, Murphy AJ et al. The Effect of Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Aspirin on Clinical Outcomes in the Healthy Elderly: A Sub-Study of the Aspirin in Reducing Events in the Elderly (ASPREE) Randomized Controlled Trial. Blood. 2022 Nov 15;140(Supplement 1):2238-2239. doi: 10.1182/blood-2022-170761